Diagnosis and Management of Chylous Ascites
Diagnostic Evaluation
- Cell count with differential should be obtained on ascitic fluid to rule out spontaneous bacterial peritonitis (neutrophils > 250 cells/mm³) and to screen for malignant cells. 1
- Ascitic fluid albumin and total protein must be measured to enable calculation of the serum‑ascites albumin gradient (SAAG) and to assess infection risk. 1
- If infection is suspected, at least 10 mL of ascitic fluid should be inoculated directly into blood‑culture bottles at the bedside. 1
Determining Underlying Etiology
- Serum albumin should be drawn on the same day as paracentesis; SAAG is calculated by subtracting ascitic fluid albumin from serum albumin. 2
- A SAAG ≥ 1.1 g/dL indicates portal‑hypertension‑related ascites with ≈ 97 % accuracy, pointing to cirrhosis, cardiac failure, or Budd‑Chiari syndrome as likely causes. [2][3]
- A SAAG < 1.1 g/dL suggests non‑portal‑hypertension etiologies such as peritoneal carcinomatosis, tuberculous peritonitis, or lymphatic obstruction. 3
Imaging
- Contrast‑enhanced CT with lymphography can delineate the thoracic duct and its connections to the peritoneal cavity, aiding surgical planning when an anatomic leak is suspected. 4
Management Strategies
- A diet enriched with medium‑chain triglycerides (MCT) is recommended because MCTs are absorbed directly into the portal circulation, bypassing the lymphatic system. 4
- When conservative measures fail and the thoracic duct leak is precisely localized, surgical ligation or endovascular embolization of the duct should be considered. 4
- Creation of a pericardio‑peritoneal window is an alternative surgical option for patients with persistent chylous accumulation despite other therapies. 4
- If a drug is identified as the cause of lymphatic disruption, discontinuation of the offending medication is advised. 4
Safety Considerations
- Coagulopathy does not contraindicate paracentesis; major bleeding complications occur in only about 1 % of procedures. 1
- Routine prophylactic administration of fresh frozen plasma or platelets before paracentesis is not supported by evidence and should be avoided. [2][1]
Diagnosis of Chylous Ascites
Diagnostic Approach
- The diagnosis of chylous ascites is established by demonstrating a triglyceride level >200 mg/dL in ascitic fluid obtained by paracentesis, which typically appears white and milky on gross examination 5, 6
- White, milky fluid on gross examination is the hallmark visual finding that should immediately raise suspicion for chylous ascites 5, 6
- Ascitic fluid triglyceride level >200 mg/dL confirms the diagnosis 5, 6
- Triglyceride levels often exceed 1,000 mg/dL in true chylous ascites 5, 6
Standard Ascitic Fluid Analysis
- Cell count with differential to assess for infection or malignancy should be performed on the initial paracentesis specimen 7, 5
- Albumin concentration to calculate the serum-ascites albumin gradient (SAAG) should be performed on the initial paracentesis specimen 7
- Total protein concentration should be performed on the initial paracentesis specimen 7
- Culture if infection is suspected should be performed on the initial paracentesis specimen 7
Determining Underlying Etiology
- Calculate SAAG to distinguish portal hypertension-related causes (SAAG ≥1.1 g/dL indicates portal hypertension with 97% accuracy) 5, 7